Detalles de la búsqueda
1.
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 25(3): 233-243.e8, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38105153
2.
Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations.
Eur J Cancer
; 167: 142-148, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35307254
3.
Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapy.
Eur J Cancer
; 145: 221-229, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33516050
Resultados
1 -
3
de 3
1
Próxima >
>>